Articles‎ > ‎

2018

Ethical Issues Plagued Newly Surfaced Paper by "CRISPR Babies" Scientist (December 10)

The 'CRISPR Babies' Experiment Was More Flawed Than Scientists First Realized (December 5) 

'CRISPR Babies' Lab Asked US Scientist for Help to Disable Cholesterol Gene in Human Embryos (December 4)

Archived Chat: Gene-Edited Babies and the Future of CRISPR (November 30)

China Halts Genome-Editing Work That Led to Claimed Birth of CRISPR Babies (November 29)

Amid Uproar, Chinese Scientist Defends Creating Gene-Edited Babies (November 28)

He Took a Crash Course in Bioethics. Then He Created CRISPR Babies (November 27)

An Outsider Claimed to Make Genome-Editing History--And The World Snapped to Attention (November 26)

Claim of CRISPR'd Baby Girls Stuns Genome-Editing Summit (November 26) 

As a Genome-Editing Summit Opens in Hong Kong, Questions Abound Over China, and Why It Quietly Bowed Out (November 26)

CRISPR Tracker: CRISPR Advances are Coming Fast, Here's Your Guide (Multiple dates)

Offering Free DNA Sequencing, Nebula Genomics Opens for Business. But There's An Itsy-Bitsy Catch (November 15) 

With Brain Implants, Scientissts Hope to Translate Paralyzed Patients' Thoughts Into Speech (November 15)

Life Span Has Little To Do With Genes, Analysis of Large Ancestry Database Shows (November 6) 

New Prize Offers $2 Million for Finding Key to Alzheimer's in Past Research (November 5)

It Started As A 'Weird Idea," But A New Studys Shows The Appendix Can Initiate Parkinson's (October 31)

ER Patients Given Ketamine, Other Powerful Drugs in Clinical Trials Without Their Consent, FDA Finds (October 29) 

How an Outsider in Alzheimer's Research Bucked the Prevailing Theory--And Clawed for Valdation (October 29)

(Live Chat) Nobel Laureate James Allison Looks to the Future of Cancer Immunotherapy (October 17)

New Microscope Shows Mouse Embryos Developing, Second by Second, Cell by Cell (October 11)

CRISPR Cures Inherited Disorder in Mice, Paving Way for Genetic Therapy Before Birth (October 8)

Nobel Physics Prize Honors Laser Discoveries That Advanced Eye Surgery, Virus Manipulation (October 2)

A Pioneer in Cancer Immunotherapy Sees a Future Where Vaccines, CAR-T and Checkpoint Inhibitors Come Together (October 1) 

Nobel Prize in Medicine Awarded to Two Cancer Researchers for Immune System Breakthrough (October 1) 

The Snub Club: Crucial Contributors to Cancer Immunotherapy Were Excluded from the Medicine Nobel (October 1) 

You Have Questions About How to Best Analyze Clinical Trials. We Have Answers (Mailbag) (September 28) 

How to Interpret Clinical Trials Like a Pro (webinar) (September 25)

In Response to Critic, NIH Alcoholism Instutute Changes Online Explanation of Cancer Risk from Drinking (September 17) 

For CRISPR Patents, the Ugliest Phase May Still Be To Come (September 17)

Health Researcher Calls on NIH to Retract Statement About Alcohol and Cancer Risk (September 13) 

Study Cracks Open the Secrets of the Cancer-Causing BRCA1 Gene (September 12)

CRISPR's Hedgehog Problem: Rolled-Up Genes Can't Be Edited, Study Finds (September 10)

Appeals Court Upholds CRISPR Patents Awarded to The Board Instutute (September 10)

That Alarm About the Cancer Risks of CRISPR? It's Still Ringing (September 10)

After Cancer Spreads, A Single Drug Should Work Against All The Tumors, Study Suggests (September 6)

First CRISPR Clinical Trial Backed by US Companies Launches (August 31)

CRISPR Fixed Duchenne Muscular Dystrophy in Beagles. Will This Technique Overtake an Older Gene Therapy? (August 30)

Watchdog Group Calls for NIH to Halt "Dangerous" Study of Sepsis Treatment (August 28) 

John McCain Has Died. For Brain Cancers Like His, 'Research Is Our Only Hope' (August 25)

'Microdosing' Is Touted by 'Shroomers and Reddit Users. Science is Starting to Test Their Claims--And Finding Some Truth (August 23)

Overlooked Molecule Might Be Key to How Well Cancer-Fighting CAR-T Cells Work (August 21) 

Newest Form of CRISPR Corrects Genetic Disease in Viable Human Embryos, With Few Errors (August 20)

As Alzheimer's Drug Developers Give Up on Today's Patients, Where Is The Outrage? (August 15)

That Pathetic Alzheimer's Pipeline? It's Even Worse Than You Think (August 10) 

After 30 Years, An Immunotherapy to Rival CAR-T Finally Nears the Clinic (August 9)

Those CRISPR'd Human Embryos? We Got It Right, Scientists Insist, Rejecting Criticism (August 8)

Assembling Yeast Chromosomes Like LEGOs Has a Serious Goal: Safe Lab-Made Creatures (August 1)

Out of Prison, the "Father of Gene Therapy" Faces a Harsh Reality: A Tarnished Legacy and an Ankle Monitor (July 23) 

New Challenge Filed to CRISPR Patent Licensed by Editas Medicine (July 17) 

That CRISPR Study: In The Cold, Clear Light of Morning, Why It's Raising Concerns (July 17)

Potential DNA Damage From CRISPR Has Been "Seriously Underestimated," Study Finds (July 16)

CRISPR Makes Cancer Cells Turncoats That Attack Their Tumor, Mouse Study Finds (July 11)

Hope for Creaky Old Humans: Removing Aged Cells from Mice Can Restore Their Youth, Study Finds (July 9) 

Can Zapping People's Brains Reduce Violence? Controversial Study Sees Potential (July 2) 

Psychiatrists Call for Rollback of Policy Banning Discussion of Public Figures' Mental Health (June 28)

New Study Supports Long-Dismissed Idea: Herpes Viruses Could Play a Role in Alzheimers (June 21)

Controversial Researcher's Diabetes Vaccine Causes Improvement in Small Study (June 21)

Transcript: Live Chat, Last week in CRISPR — cancer, patents and a dip in the market (June 19)

Controversial NIH Study of 'Moderate Drinking' Will Be Terminated After Scathing Report (June 15) 

Why Reports about CRISPR'd Cells and Cancer Are Not Calamitous--But Shouldn't Be Ignored (June 15) 

The University of California Will Finally Be Granted Two CRISPR Patents (June 13)

Alcohol Study Failed to Seek FDA Approval, Possibly Violating Federal Rules (June 12)

A Serious New Hurdle for CRISPR: Edited Cells Might Cause Cancer, Find Two Studies (June 11) 

From One Breast Cancer Patient's Turnaround, Clues to a New Immunotherapy (June 4)

ASCO In 30 Seconds: Wall Street Speaks. Wall Street's Reaction and Patient-Reported Outcomes (June 4) 

ASCO In 30 Seconds: Biotech Battleground. Immunotherapy Controversy and Less is Just As Good (June 3)

Grail's Cancer Blood Test Shows 'Proof of Principle," But Challenges Remain (June 2) 

ASCO In 30 Seconds: A Clinical Trial That Keeps on Giving. 5-Year Keytruda Data & Winners and Losers (June 2) 

CRISPR Advances Are Coming Fast. Here's Your Guide (June 1)

ASC0 In 30 Seconds: And Now It Starts. So It Begins & The Best Health Care System (June 1) 

Schizophrenia 'Risk Genes' Are Not So Risky If the Mother's Pregnancy Was Healthy (May 28)

Scientific Luminaries Threw James Watson a Birthday Party Weeks Before Eric Lander's Widely Criticized Toast (May 17)

A Pencil, Not A Pair of Scissors: CRISPR Pioneers' New Company Bets on Base Editing to Cure Disease (May 14)

CAR-T is a Personalized Attack on Cancer. Here's How It Works (May 14)

For Cancer Immunotherapies, A Radioactive Crystal Ball Might Foretell Success or Failure (May 14) 

As Twitter Explodes, Eric Lander Apologizes for Toasting James Watson (May 14)

In 'Beautiful Brain," the Secrets of Neurons Emerge in Nobel-Winning Scientist's Ink-and-Pencil Drawings (May 3) 

As CRISPR Patent Fight Nears the Endgame, Where Are Settlement Talks? (May 2)

Genome 'Writers' Set Their First Goal: Recoding Human Cells to Resist Viruses (May 1)

'It's Going To Be Tough:' UC Berkeley Struggles to Find Sympathetic Court in CRISPR Patent Appeal (April 30)

All You Need to Know for Round 2 of the CRISPR Patent Fight (April 27)

Doudna's Latest CRISPR Company Debuts, Joining the Crowds in Diagnostics and Genome-Editing (April 26)

Miniature Human Brains Grow for Months When Implanted in Mice Skulls (April 16)

Cancer Surgery Can Awaken Tumor Cells, But in Mice a Cheap Pill Stops Metastasis (April 11) 

Scientists Are Thinking the Unthinkable: CRISPR Might One Day Reverse Devastating Brain Diseases (April 9)

New Alcohol-Advertising Research Stopped With NIH Branch Director's Arrival (April 4)

The Code is a 3-Part Video Series Investigating the Roots of Today's Most Promising Genetic Technologies (April 2)

NIH Rejected a Study of Alcohol Advertising While Pursuing Industry Funding for Other Research (April 1)

CAR-T is a Personalized Attack on Cancer. Here's How It Works (March 29)

Sequencing Patients' Genomes Might Not Break the Health-Care Bank, Study Finds (March 22)

A Dietary Supplement Makes Old Mice Youthful. But Will It Work In People? (March 22)

Stealth Biotech Arbor Steps Out of the Shadows, Announcing It's Found a New CRISPR Enzyme (March 15)

Columbia's Dismissal of Prominent Neuroscientist Prompts Demand for Answers (March 12)

Controversial Study Challenges Scientific Consensus That Adult Brains Make New Neurons (March 7)

FDA Approves First Direct-to-Consumer Test for Breast Cancer Risk (March 6)

CRISPR 'Gone Wild' Has Made Stocks Swoon, But Studies Show How to Limit Off-Target Editing (March 5)

You Have Questions on Genome-Editing. We Have Answers (Webinar, with Adam Feuerstein, February 27)

With DNA from a Museum Specimen, Scientists Reconstruct the Genome of a Bird Extinct for 700 Years (February 27)

Matching DNA to a Diet Doesn't Work: 'We Didn't Even Come Close,' Researcher Says (February 20)

With New CRISPR Inventions, Its Pioneers Say, You Ain't Seen Nothin' Yet (February 15)

Optogenetics 2.0: Brain Control Goes Wireless Via Light, Sound or a Drug (February 8)

With Startup, George Church Bets Cryptocurrency Will Boost Genome Sequencing (February 7) 

A CRISPR Trick in Blind Mice Points the Way to Possible Treatments of Inherited Diseases (February 2)

Heart Group Warns of Cardiovascular Risks After Treatment for Breast Cancer (February 1)

Hand-Held DNA Sequencer Closes Gaps in Human Genome, Challenges Industry Leader (January 29)

Brain Organoids as Repair Kits for Stroke Damage Inch Closer to Reality (January 25)

What Can We Learn From the Latest Alzheimer's Drug to Fail? (January 24)

In a Scientific First, Cloned Monkeys Are Born. Will They Accelerate Biomedical Research? (January 24) 

Too Good To Be True? Experts Clash on Whether Hitting the Gym Helps the Brain (January 19) 

Trump's Doctor Says He Has 'Incredible Genes.' Will They Keep Protecting His Health? (January 17)

Trump Administration Halts "Evidence-Based" Program That Evaluates Nehavioral Health Therapies (January 10) 

How to Determine Trump's Mental Fitness for Office? Experts Point to Reliable Cognitive Tests (January 9)

'Failed' Alzheimer's Drug Looks Better With Additional Analysis, Neurotrope Says (January 5)

Preliminary Study Hits that Genetically Modified T Cells Might Fight HIV (January 2)

Too Much Screening Has Misled Us About Real Cancer Risk Factors, Experts Say (January 1) 


Comments